Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Oncologist Support for Euthanasia Declines

By HospiMedica staff writers
Posted on 10 Oct 2000
A survey of 3,299 oncologists has revealed that the support for euthanasia and physician-assisted suicide of terminally ill cancer patients has dramatically declined in recent years. More...
The survey also found that oncologists who had been trained in end-of-life care were less likely to support or carry out euthanasia or physician-assisted suicide. The researchers who conducted the survey say this may reflect an improved ability by some oncologists to provide appropriate care for their dying patients.

A study that compared the results of this survey, conducted in 1998, with a survey conducted in 1994 showed that support for euthanasia for dying cancer patients in excruciating pain has dropped from 23% in 1994 to 7% in 1998. Similarly, support for physician-assisted suicide for terminally ill cancer patients with unremitting pain has dropped from 45% to 22%. The study results were published in the October 3 issue of the Annals of Internal Medicine.

In the recent survey, nearly one-third of the oncologists who participated said they would be reluctant to increase the dosage of morphine for a dying cancer patient in excruciating pain. This reticence to relive pain appears to reflect physician fears that increasing the dose of morphine may also raise a patient's risk of respiratory depression and death, which might be construed as euthanasia. The participants in the survey were members of the American Society of Clinical Oncology (ASCO).

These study results underscore the need for physician education of optimal pain and palliative care practices, said Robert J. Mayer, M.D., professor of medicine at Harvard Medical School and leader of the study. Physicians who are better informed about end-of-life issues feel less need to use euthanasia and physician-assisted suicide.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.